Here are some companies that are making headlines in intraday trading. Tyson Foods — Shares fell nearly 7% after the food company lowered its full-year outlook, citing pressure on beef. Tyson now expects adjusted operating income in 2026 to be between $1.85 billion and $2.05 billion, down from $2.1 billion to $2.3 billion. Full-year sales growth is pegged at 1.5% to 2%, compared with previous expectations of 2.5% to 3.5%. Metaplatform — Shares rose 3% following the rollout of Instagram parent company’s artificial intelligence model Muse Spark 1.3. Dell Technologies — Shares of the laptop and server maker rose for a second day, rising 5% in midday trading. Earlier this week, Dell reported better-than-expected quarterly results for revenue and bottom line, and raised its forecast for fiscal 2027. Coinbase , Strategy — Stocks of companies related to cryptocurrencies rose after Bitcoin soared more than 4% to trade above $80,000. At one point, the flagship cryptocurrency reached its highest level since May 15th. Shares of crypto trading platform Coinbase rose 10%, while shares of Bitcoin treasury company Strategy rose 13%. Riot Platforms stock rose 11%. Robinhood — The trading app’s stock rose 15% after Deutsche Bank released a report predicting market tailwinds for brokers, asset managers and exchanges. The bank believes corporate financial key performance indicator contracts may offer the strongest growth potential in prediction markets, and sees Robinhood as a beneficiary. SIENA — The optical networking company’s stock fell 9%. Revenue guidance for the fiscal year ending in October is $6.42 billion plus or minus $50 million, compared with the FactSet consensus of $6.34 billion. The outlook overshadowed third-quarter top and bottom results that beat street expectations. Tesla — The electric car maker’s stock rose more than 6% ahead of the company’s CyberCab event scheduled for after the close. Tesla plans to unveil its two-seater robotaxis at an event in Austin, Texas, on Thursday night. Shares of Elon Musk’s space company SpaceX followed suit, rising nearly 6%. Snowflake — Shares rose about 22% after second-quarter results beat analysts’ expectations. For the quarter, Snowflake posted adjusted earnings of 62 cents per share on revenue of $1.55 billion. Analysts surveyed by LSEG had expected earnings of 45 cents a share and revenue of $1.48 billion. Snowflake also raised its full-year product revenue outlook. Software stocks — Snowflake lifted its software peers. Datadog stock rose more than 2%, and ServiceNow stock rose nearly 6%. Salesforce stock rose more than 3%. Hewlett Packard Enterprise — The enterprise technology company’s stock fell 4%. HPE is projecting earnings growth of 16% to 20% for the fiscal year ending October 2027, compared to the FactSet consensus forecast for an 18.7% increase. Cash flow is expected to be at least $5 billion in the period, compared to the Street’s forecast of $4.79 billion. Broadcom — The company’s stock fell 3% as investors reacted negatively to fourth-quarter revenue estimates of $35.03 billion versus the consensus estimate of $35.03 billion. Non-GAAP operating margin estimates for the fourth quarter were 66%, below expectations of 66.5%. Broadcom reported third-quarter revenue of $29.59 billion and adjusted earnings per share of $3.32. Campbell’s Co. — Shares of the food and beverage company fell 9% after the company reported a weaker-than-expected fiscal year 2027 profit outlook. Campbell’s expects fiscal 2027 earnings per share, excluding one-time items, to be between $1.65 and $1.80, while the FactSet consensus is $1.83 per share, and expects revenue growth to contract at a faster pace than expected. Ultragenyx Pharmaceutical — Shares plunged 44% after Ultragenyx reported results from a Phase 3 trial of its drug to treat Angelman syndrome, a rare genetic neurodevelopmental disorder, did not meet its primary endpoint. The company said it was disappointed with the results and would evaluate its development program for the drug and implement significant cost reductions. Moderna — Shares fell more than 4% after the vaccine maker was downgraded to sell by Rothschild & Co. Redburn. Analysts said the stock was now overvalued after surging significantly following the success of an experimental cancer vaccine trial against melanoma. Argan — Engineering and construction stocks rose 4% after Argan reported better-than-expected second-quarter profits and sales. Argan earned $3.76 per share, beating the $2.64 per share expected by analysts surveyed by FactSet. Revenue of $384 million exceeded analysts’ consensus estimate of $300.5 million. Victoria’s Secret — Shares fell more than 13% after Victoria’s Secret missed second-quarter revenue estimates. According to a survey of analysts compiled by FactSet, the company’s operating profit forecast for the current quarter was lower than expected, but full-year sales were in line with the company’s forecast. Adjusted profit for the second quarter exceeded expectations. Netskope — The cybersecurity company’s stock soared 12%. Netskope expects full-year sales of $888 million to $892 million, beating LSEG’s consensus estimate of $881 million. Netskope expects an adjusted loss of 15 cents per share for the current period, below analysts’ consensus estimate of a loss of 18 cents per share. NetApp — The data infrastructure company fell 8%. NetApp expects fiscal second quarter non-GAAP gross margin to be 67% to 68%, down from 70.6% in the first quarter, and second quarter non-GAAP operating margin to 30.9% to 31.9%, compared to the prior quarter’s performance of 31.9%. Deferred revenue totaled $4.85 billion in the first quarter, below the consensus consensus estimate of $4.86 billion. —CNBC’s Michelle Fox, Nick Wells, Sean Conlon and Tobias Burns contributed reporting.
